Beyond Air, Inc. Form 8-K Summary
Business Context and Reporting Period
Beyond Air, Inc. (XAIR), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on December 10, 2019. The report details a material definitive agreement entered into on December 10, 2019, and the subsequent closing of a public offering and concurrent private placement on December 12, 2019.
Key Financial Metrics
The filing focuses on capital raising activities rather than operational performance metrics. Key financial figures include:
- Public Offering Shares: 2,325,000 shares of common stock.
- Public Offering Price: $3.66 per share to the public; $3.4038 per share to underwriters.
- Over-Allotment Option: Underwriters had a 30-day option for up to 348,750 additional shares. This was partially exercised on December 12, 2019, for 295,199 shares.
- Concurrent Private Placement: 532,786 unregistered shares sold to existing investors at $3.66 per share.
- Net Proceeds: Approximately $10.2 million from the public offering (including the partial over-allotment exercise), after deducting underwriting discounts, commissions, and estimated offering expenses.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as of the reporting date.
Material Changes
The primary material change is the significant increase in the company's share count and cash reserves resulting from the completed equity offering. The company issued a total of approximately 3.15 million new shares (2,325,000 initial public shares + 295,199 over-allotment shares + 532,786 private placement shares) in a single transaction window.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the offering. The Underwriting Agreement contains customary representations, warranties, indemnification obligations, and termination provisions. The private placement shares were issued in reliance upon an exemption from registration pursuant to Section 4(a)(2) of the Securities Act. No specific forward-looking guidance, risk factors, or unusual items regarding future operations were disclosed in this specific filing.
Investor Verification Checklist
- Verify the final number of shares issued after the full expiration of the 30-day over-allotment option period.
- Confirm the exact amount of net proceeds received after all offering expenses are finalized.
- Review the company's most recent 10-K or 10-Q to assess how the $10.2 million in proceeds impacts the balance sheet and liquidity position.
- Check for any lock-up agreements or restrictions on the sale of the private placement shares.